Novel Pulmonary Hypertension Drug From Bayer Shows Modest Promise In Phase 3...
A new drug appears to have promising– but not game-changing– effects in people with two forms of pulmonary hypertension. Riociguat, a soluble guanylate cyclase stimulator under development by Bayer, is...
View ArticlePositive Results For New Oral Drug From Actelion
Actelion has announced positive top-line results for a phase III trial of a new oral drug for the treatment of pulmonary arterial hypertension (PAH). The drug, selexipag, is a first-in-class orally...
View Article
More Pages to Explore .....